Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

3.1K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
3.1K
Humoral Immune Responses01:36

Humoral Immune Responses

86.3K
Overview
86.3K
Development of Immunocompetence01:22

Development of Immunocompetence

1.2K
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.2K
Immunological Memory01:23

Immunological Memory

17.9K
Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
17.9K
Tumor Immunotherapy01:27

Tumor Immunotherapy

2.3K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.3K
Immunoprecipitation01:20

Immunoprecipitation

7.9K
Immunoprecipitation, or IP, is a widely used technique that employs protein-antibody interactions to isolate proteins or protein complexes in their native state for studying protein-protein interactions, quaternary structures, or supramolecular complexes. Various modifications of the technique, including chromatin IP, cross-linking IP, and fluorescence IP, are commonly used.
Chromatin Immunoprecipitation
Chromatin immunoprecipitation, also known as ChIP, is used to study protein-DNA or...
7.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Common food allergen education and exposure in infants with feeding tubes: A single-center retrospective study highlighting an educational gap.

Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition·2026
Same author

Successful treatment of eosinophilic esophagitis with dupilumab in patients under 1 year of age or less than 15 kg: a retrospective chart review of 10 patients.

The journal of allergy and clinical immunology. In practice·2026
Same author

Reply to: Comment on: Investigating Biomarkers for Inborn Errors of Immunity in a Prospective Study of Patients With Autoimmune Cytopenia.

Pediatric blood & cancer·2026
Same author

Risk Factors for Secondary Immunodeficiency in the Aged.

The journal of allergy and clinical immunology. In practice·2026
Same author

2025 Inborn errors of immunity practice parameter: Guidance from the Joint Task Force on Practice Parameters, the American Academy of Allergy, Asthma & Immunology (AAAAI), the American College of Allergy, Asthma and Immunology (ACAAI) and the Clinical Immunology Society (CIS).

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2026
Same author

Recommended Vaccines for Immunocompetent Older Adults: A Work Group Report of the AAAAI Asthma, Allergic & Immunologic Diseases in Older Adults Committee.

The journal of allergy and clinical immunology. In practice·2026

Related Experiment Video

Updated: Apr 1, 2026

Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells
10:32

Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells

Published on: June 5, 2015

19.5K

Immunoglobulin Replacement Therapy for Primary Immunodeficiency.

Panida Sriaroon1, Mark Ballow1

  • 1Division of Allergy and Immunology, Department of Pediatrics, University of South Florida, 140 7th Avenue South, CRI 4008, Saint Petersburg, FL 33701, USA.

Immunology and Allergy Clinics of North America
|October 12, 2015
PubMed
Summary
This summary is machine-generated.

Immunoglobulin replacement therapy is a standard treatment for primary immunodeficiency, aiming to prevent infections. Newer formulations and subcutaneous administration improve safety and quality of life for patients.

Keywords:
IVIGImmunoglobulin replacement therapyIntravenous immunoglobulinPrimary immunodeficiencySCIGSubcutaneous immunoglobulin

More Related Videos

Transduction and Expansion of Primary T Cells in Nine Days with Maintenance of Central Memory Phenotype
08:49

Transduction and Expansion of Primary T Cells in Nine Days with Maintenance of Central Memory Phenotype

Published on: March 18, 2020

11.7K
Characterization of Thymus-dependent and Thymus-independent Immunoglobulin Isotype Responses in Mice Using Enzyme-linked Immunosorbent Assay
06:15

Characterization of Thymus-dependent and Thymus-independent Immunoglobulin Isotype Responses in Mice Using Enzyme-linked Immunosorbent Assay

Published on: September 7, 2018

9.9K

Related Experiment Videos

Last Updated: Apr 1, 2026

Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells
10:32

Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells

Published on: June 5, 2015

19.5K
Transduction and Expansion of Primary T Cells in Nine Days with Maintenance of Central Memory Phenotype
08:49

Transduction and Expansion of Primary T Cells in Nine Days with Maintenance of Central Memory Phenotype

Published on: March 18, 2020

11.7K
Characterization of Thymus-dependent and Thymus-independent Immunoglobulin Isotype Responses in Mice Using Enzyme-linked Immunosorbent Assay
06:15

Characterization of Thymus-dependent and Thymus-independent Immunoglobulin Isotype Responses in Mice Using Enzyme-linked Immunosorbent Assay

Published on: September 7, 2018

9.9K

Area of Science:

  • Immunology
  • Hematology
  • Pharmacology

Background:

  • Immunoglobulin replacement therapy (IRT) has been a cornerstone in managing primary immunodeficiency diseases (PIDs) for over 30 years.
  • The primary objective of IRT is to mitigate serious bacterial infections in patients with impaired antibody production.
  • Despite its efficacy, a significant portion of patients on intravenous immunoglobulin (IVIg) experience adverse reactions.

Purpose of the Study:

  • To provide a comprehensive review of immunoglobulin therapy in primary immunodeficiency diseases.
  • To discuss the properties, optimal dosing strategies, and adverse effects associated with IRT.
  • To explore the evolving routes of administration and their impact on patient outcomes.

Main Methods:

  • This review synthesizes current literature on immunoglobulin therapy for PIDs.
  • It examines advancements in manufacturing processes leading to improved product safety and tolerability.
  • The review analyzes data on subcutaneous versus intravenous immunoglobulin administration.

Main Results:

  • Recent manufacturing innovations have yielded safer and better-tolerated immunoglobulin products.
  • Subcutaneous immunoglobulin (SCIg) self-infusion is increasingly adopted, correlating with enhanced patient quality of life.
  • Understanding of dosing, adverse events, and administration routes is crucial for effective IRT.

Conclusions:

  • Immunoglobulin therapy remains essential for managing PIDs, with ongoing improvements in safety and patient experience.
  • The shift towards subcutaneous administration represents a significant advancement, offering improved tolerability and quality of life.
  • Continued research and development in IRT are vital for optimizing patient care in primary immunodeficiencies.